Margins on Watch: Can Radico Sustain Blowout Profitability into H2?
Q1's 76% profit surge and record 20.7% EBITDA margin reset expectations hard. Street watches if premiumization momentum and operational leverage hold in Q2, as valuations price in sustained excellence.
The Setup: Margin Durability in Focus
Radico Khaitan opened FY27 with a blowout—consolidated PAT jumped ~76% YoY to ₹230 Cr on gross revenue of ₹5,868 Cr (up 10.4% YoY), but the real story was margin architecture. EBITDA reached a record 20.7% (up 536 bps YoY), gross margin climbed to 49.1%, and the Prestige & Above segment (higher-margin spirits) surged 36% YoY. Magic Moments vodka—the flagship—grew 43% with 60%+ market dominance. Q1 was not a one-time pop; it was the execution of a premiumization thesis. Q2 will test whether the Street's thesis holds: can Radico sustain elevated margins and volume growth as the quarter typically carries monsoon-season headwinds?
~₹1,700–₹1,750 Cr
tracking Q1's ~12% YoY growth run-rate; on-plan if Prestige & Above momentum and Magic Moments hold
~19–21%
Q1's 20.7% was record; sustainability is the question—commodity costs, excise shifts, and product mix will move the needle
~₹220–₹250 Cr
if margin structure holds and revenue grows on plan, low-teens% net profit growth vs Q1 is plausible; upside if P&A accelerates further
~30%+ growth expected
management guided 25%+ for full FY27; Q2 momentum from UK airports (Sep launch), new flavours (Aam Panna Vodka, Aug), and summer base should support
A strong Q2 print would show revenue growth at 10%+ on net-of-excise basis, EBITDA margin ≥19%, and continued P&A segment volume acceleration. Gross margin staying 48%+ signals premiumization is real, not temporary. A weak print would see EBITDA margin compress >200 bps from Q1 (commodities, excise normalization, mix dilution) or P&A growth slip below 20%—signalling the margin cycle may be peaking and Street's 25% FY27 target is at risk.
On Track with Guidance?
Management raised the Prestige & Above volume growth target to 25%+ for full-year FY27 (from 20%), and guided for continued premiumization across portfolio—domestic and export. The UK airport presence (Rampur, Sangam luxury whisky in four major hubs as of late Sep) and new product launches (Aam Panna Vodka, Aug; flavoured moonshine variants) are execution flags supporting that raise. Q1's margin beat (+536 bps EBITDA) was driven by product mix (P&A at higher ASPs), operational leverage, and likely some one-time tailwinds (lower input costs, excise favorability). The debate is whether 20%+ EBITDA is structural or cyclical. If Q2 sustains >19% and P&A volume growth stays 30%+, the thesis holds. If either cracks, the market will reprice expectations lower.
Since Last Quarter: The Event Scan
1 · UK Airport Expansion (Sep 28) — Growth Signal
Radico launched luxury whisky brands (Rampur, Sangam) across Heathrow, Gatwick, Manchester, Birmingham—first Indian spirits player in all four. This validates international premiumization strategy and opens high-margin export channel. Watch for Q2 commentary on order intake and timing of revenue recognition.
2 · New Product Launches (Aug) — Portfolio Breadth
Magic Moments Aam Panna Vodka (flavoured) launched as part of 'Flavours of India' sub-brand. Part of innovation rhythm to maintain Magic Moments 43% YoY growth from Q1. Low risk; extends within core brand.
3 · ESG Ratings (Oct, Aug) — Governance & Compliance
NSE Sustainability rated Radico 69/100 (Oct 16); CRISIL ESG rated 58 (Aug 11); Niche Ninety Nine rated 62 (Sep 18). Routine updates; all in mid-range bands. No material governance issues flagged.
4 · Management Appointments (Jul 28) — Ops Strength
Sudhir Upadhyay appointed Chief Sales Officer, Kunal Madan Chief Marketing Officer. Mid-level executive moves; signals investment in sales and brand management. Routine.
5 · Auditor Re-Appointment (Aug 7) — No Red Flags
Walker Chandiok & Co re-appointed for second 5-year term at AGM. Continuity; no audit concerns.
What to Watch on October 27
1 · EBITDA Margin Integrity
Does EBITDA margin stay ≥19%? If it compresses to <18%, cyclical tailwinds (lower input costs, excise mix) are fading. Watch gross margin (should be 48%+) and OpEx as a % of revenue. Management commentary on commodity inflation and excise changes is critical.
2 · Prestige & Above Momentum
Volume growth in P&A segment—watch if it stays 30%+. Management raised FY27 target to 25%; if Q2 shows 25–30% growth, it's tracking well. If <20%, the acceleration may be peaking. Also watch ASP (average selling price) trajectory—premiumization only works if prices stick.
3 · FY27 Guidance Reaffirm or Raise
Will management reaffirm 25%+ P&A growth, or does Q2 evidence demand a trim? Any commentary on export ramp (UK airports, other geographies) timing and margin accretion? Guidance changes will reprrice valuation risk fast.
Radico Khaitan's Q2 report is not about growth—it's about margin durability and scale. Q1's blowout (76% profit jump, record 20.7% EBITDA) reset the valuation frame, and the Street has priced in sustained excellence at 60x FY28E. The test: can premiumization and operational leverage persist into H2, or was Q1 the peak of the cycle? Revenue in-line with 10%+ growth and EBITDA ≥19% would validate the thesis and likely hold the stock in a ₹4,500–₹5,100 range. A margin miss or P&A slowdown would invite sharp repricing lower. Watch the gross margin, P&A volume narrative, and full-year guidance reaffirm most closely.
Informational and educational content only. Not investment advice.